Register entry
Piramal Healthcare (Canada) Limited
Data as of · How to read this entry
- Registered sites
- 8
- Active NDC listings
- 86
- Labeller names
- 4
- Live patents
- 0
- Countries
- 4
- Base
- India
Authorisation
Registered operations
Analytical testing7Active ingredient (API) manufacture5Labelling3Finished drug manufacture5Packaging3particle size reduction1
Sites
Registered establishments
8| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Piramal Healthcare (Canada) Limited | 110 Industrial Pky N, Aurora, ON L4G 3H4, Canada (CAN) | Analytical testing, Active ingredient (API) manufacture | 3002808377244133364 |
| Piramal Healthcare UK LimitedRegistrant: Piramal Pharma Limited | Whalton Road, Morpeth, Northumberland, England NE61 3YA, United Kingdom (GBR) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3002808116345609965 |
| Piramal Healthcare UK LimitedRegistrant: Piramal Pharma Limited | 2 Roseland Hall, Earls Gate Park, Grangemouth,, Stirlingshire, Scotland FK3 8ZF, United Kingdom (GBR) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3003723155235591037 |
| Piramal Pharma Limited | Plot No.19 PHARMEZ, Village Matoda Sarkhej-Bawla NH. No.8A, Taluka Sanand, Ahmedabad, Gujarat 382213, India (IND) | Analytical testing | 3008394466677604091 |
| Piramal Pharma Limited | C-43, MIDC, TTC Industrial Area, Turbhe, off Thane Belapur Road, Navi Mumbai, Maharashtra 400703, India (IND) | Active ingredient (API) manufacture | 3008763768650515294 |
| Piramal Pharma Limited | Plot No. 67-70, Sector II, District Dhar, Pithampur, Madhya Pradesh 454775, India (IND) | Analytical testing, Finished drug manufacture, Packaging | 3005259207862202793 |
| Piramal Pharma Limited | Sy.Nos. 7-70, 70/1 and 70/2, Digwal Village, Kohir Mandal, Sangareddy, Telangana 502321, India (IND) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, particle size reduction | 3003803288919067108 |
| Piramal Pharma Solutions Inc. | 1500 Bull Lea Road, Suite 250, Lexington, Kentucky (KY) 40511, United States (USA) | Analytical testing, Labelling, Finished drug manufacture | 3006419237794520721 |
Catalogue
Drug listings by form and route
8686 active NDC listings: 55 bulk ingredient, 31 drug for further processing. By marketing category: BULK INGREDIENT 55, DRUG FOR FURTHER PROCESSING 31.
| Dosage form | NDCs |
|---|---|
| powder | 63 |
| injection | 7 |
| tablet, film coated | 7 |
| aerosol | 3 |
| tablet | 2 |
| injection, powder, for solution | 1 |
| injection, powder, lyophilized, for solution | 1 |
| injection, solution | 1 |
| liquid | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| piramal pharma limited | 58 |
| piramal healthcare uk limited | 10 |
| piramal pharma solutions inc. | 10 |
| piramal healthcare (canada) limited | 8 |
Catalogue
Marketed products
86| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Abacavir Sulfate | powder | 65085-0024BULK INGREDIENT |
| - | Acyclovir | powder | 65085-0039BULK INGREDIENT |
| - | Amiodarone Hydrochloride | powder | 65085-0022BULK INGREDIENT |
| - | Aprepitant | powder | 65085-0043BULK INGREDIENT |
| - | Armodafinil | powder | 65085-0058BULK INGREDIENT |
| - | Arsenic Trioxide | injection, solution | 58621-001DRUG FOR FURTHER PROCESSING |
| - | Azilsartan Kamedoxomil | powder | 65085-0074BULK INGREDIENT |
| - | Baclofen (Process-B) | powder | 65085-0055BULK INGREDIENT |
| - | Bempedoic Acid | tablet, film coated | 24584-1120DRUG FOR FURTHER PROCESSING |
| - | Bexagliflozin | powder | 65085-0065BULK INGREDIENT |
| - | Bimatoprost | powder | 55679-113BULK INGREDIENT |
| - | Bisoprolol Fumarate | powder | 65085-0051BULK INGREDIENT |
| - | Brimonidine Tartrate | powder | 55679-133BULK INGREDIENT |
| - | Brimonidine Tartrate | powder | 65085-0030BULK INGREDIENT |
| - | Buserelin | powder | 41701-015BULK INGREDIENT |
| - | CLOBAZAM | powder | 65085-0054BULK INGREDIENT |
| - | Cabozantinib S-malate | powder | 55679-116BULK INGREDIENT |
| - | Calcitonin Salmon | powder | 41701-010BULK INGREDIENT |
| - | Carmustine | injection, powder, lyophilized, for solution | 58621-002DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | injection | 58621-011DRUG FOR FURTHER PROCESSING |
| - | Cetrorelix Powder (Synthetic) | powder | 41701-011BULK INGREDIENT |
| - | Cinacalcet Hydrochloride | powder | 65085-0052BULK INGREDIENT |
| - | Cloprostenol Sodium | powder | 24584-1114DRUG FOR FURTHER PROCESSING |
| - | Cyclophosphamide | injection | 58621-009DRUG FOR FURTHER PROCESSING |
| - | Cyclophosphamide | injection | 58621-010DRUG FOR FURTHER PROCESSING |
| - | DEFERASIROX | powder | 65085-0063BULK INGREDIENT |
| - | DEHYDRATED ALCOHOL | injection | 58621-003DRUG FOR FURTHER PROCESSING |
| - | DEXLANSOPRAZOLE | powder | 65085-0070BULK INGREDIENT |
| - | Dapagliflozin Propanediol Monohydrate | powder | 65085-0068DRUG FOR FURTHER PROCESSING |
| - | Desmopressin | powder | 41701-007BULK INGREDIENT |
| - | Deuruxolitinib Phosphate | powder | 55679-120BULK INGREDIENT |
| - | Diltiazem Hydrochloride | powder | 65085-0002BULK INGREDIENT |
| - | Donepezil | powder | 65085-0046BULK INGREDIENT |
| - | Droxidopa | powder | 65085-0071DRUG FOR FURTHER PROCESSING |
| - | ELUXADOLINE | powder | 65085-0080DRUG FOR FURTHER PROCESSING |
| - | Entacapone | powder | 65085-0050BULK INGREDIENT |
| - | Flecainide Acetate | powder | 65085-0023DRUG FOR FURTHER PROCESSING |
| - | Fosaprepitant Dimeglumine | powder | 65085-0060BULK INGREDIENT |
| - | Fostemsavir tromethamine | powder | 24584-1113BULK INGREDIENT |
| - | Glipizide | tablet | 66112-914DRUG FOR FURTHER PROCESSING |
| - | Glipizide | tablet | 66112-915DRUG FOR FURTHER PROCESSING |
| - | Gonadorelin Acetate | powder | 41701-018BULK INGREDIENT |
| - | Hydrogel | injection | 58621-005DRUG FOR FURTHER PROCESSING |
| - | Ibuprofen-L-Lysinate | powder | 55679-112BULK INGREDIENT |
| - | Isocarboxazid | powder | 55679-115BULK INGREDIENT |
| - | Isoflurane | liquid | 65085-0019BULK INGREDIENT |
| - | Ketoconazole | powder | 65085-0028BULK INGREDIENT |
| - | Labetalol Hydrochloride | tablet, film coated | 66112-919DRUG FOR FURTHER PROCESSING |
| - | Labetalol Hydrochloride | aerosol | 66112-920DRUG FOR FURTHER PROCESSING |
| - | Labetalol Hydrochloride | aerosol | 66112-921DRUG FOR FURTHER PROCESSING |
| - | Labetalol Hydrochloride | aerosol | 66112-922DRUG FOR FURTHER PROCESSING |
| - | Levobunolol Hydrochloride | powder | 65085-0029BULK INGREDIENT |
| - | Levoketoconazole | powder | 65085-0078DRUG FOR FURTHER PROCESSING |
| - | Lurasidone Hydrochloride | powder | 65085-0053BULK INGREDIENT |
| - | MISOPROSTOL | powder | 24584-1051BULK INGREDIENT |
| - | Mecamylamine Hydrochloride | powder | 65085-0075BULK INGREDIENT |
| - | Mirabegron | powder | 65085-0067BULK INGREDIENT |
| - | NALOXEGOL | tablet, film coated | 24584-1115DRUG FOR FURTHER PROCESSING |
| - | NALOXEGOL | tablet, film coated | 24584-1116DRUG FOR FURTHER PROCESSING |
| - | Ocaliva | tablet, film coated | 24584-1121DRUG FOR FURTHER PROCESSING |
| - | Ocaliva | tablet, film coated | 24584-1122DRUG FOR FURTHER PROCESSING |
| - | Oxybutynin Chloride | powder | 65085-0013BULK INGREDIENT |
| - | Oxytocin | powder | 41701-002BULK INGREDIENT |
| - | Oxytocin | powder | 41701-017BULK INGREDIENT |
| - | PALIPERIDONE PALMITATE | powder | 65085-0066BULK INGREDIENT |
| - | PARECOXIB SODIUM | powder | 24584-1125BULK INGREDIENT |
| - | POLYGLYCAN | injection | 58621-007DRUG FOR FURTHER PROCESSING |
| - | Pramipexole Dihydrochloride | powder | 65085-0056BULK INGREDIENT |
| - | Rimegepant Sulphate | powder | 65085-0081BULK INGREDIENT |
| - | Spironolactone | powder | 24584-1119DRUG FOR FURTHER PROCESSING |
| - | Succimer | powder | 65085-0072BULK INGREDIENT |
| - | TETRABENAZINE | powder | 65085-0064BULK INGREDIENT |
| - | Tafenoquine succinate | powder | 65085-0061DRUG FOR FURTHER PROCESSING |
| - | Tazarotene | powder | 55679-114BULK INGREDIENT |
| - | Terlipressin | powder | 41701-016BULK INGREDIENT |
| - | Thiotepa | injection | 58621-004DRUG FOR FURTHER PROCESSING |
| - | Tolcapone | powder | 65085-0032BULK INGREDIENT |
| - | Tramadol Hydrochloride | powder | 65085-0021BULK INGREDIENT |
| - | Trazodone Hydrochloride | powder | 65085-0014BULK INGREDIENT |
| - | VARENICLINE TARTRATE | powder | 65085-0073BULK INGREDIENT |
| - | Vasopressin | powder | 41701-008BULK INGREDIENT |
| - | Verapamil Hydrochloride | powder | 65085-0026BULK INGREDIENT |
| - | Verdinexor | powder | 55679-119BULK INGREDIENT |
| - | Vibegron | powder | 65085-0079DRUG FOR FURTHER PROCESSING |
| - | bempedoic acid and ezetimibe | tablet, film coated | 66112-913DRUG FOR FURTHER PROCESSING |
| - | rabacfosadine succinate | injection, powder, for solution | 58621-006DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
12- Zydus Lifesciences LimitedAhmedabad, IND · 7 sites
- Amneal Pharmaceuticals of New York, LLCAhmedabad, IND · 6 sites
- Apitoria Pharma Private LimitedSangareddy, IND · 5 sites
- Dr. Reddy's Laboratories LimitedSangareddy, IND · 3 sites
- Intas Pharmaceuticals LimitedAhmedabad, IND · 3 sites
- Arene Life Sciences Private LimitedSangareddy, IND · 3 sites
- Lupin LimitedPithampur, IND · 2 sites
- Viyash Scientific LimitedSangareddy, IND · 2 sites
- Aurobindo Pharma LimitedSangareddy, IND · 2 sites
- Sandoz Industrial Products S.ANavi Mumbai, IND · 2 sites
- Honour Lab LimitedSangareddy, IND · 2 sites
- Concord Biotech LimitedAhmedabad, IND · 2 sites
Compare
Comparable companies in India
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- MSN Laboratories Private Limited,8 sites · 275 NDC
- Hetero Labs Limited8 sites · 167 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Biocon Biologics Limited9 sites · 176 NDC
- Ipca Laboratories Limited7 sites · 77 NDC
- Indoco Remedies Limited7 sites · 58 NDC
- Viyash Scientific Limited9 sites · 58 NDC
Enquiry
Common questions
- Is Piramal Healthcare (Canada) Limited FDA approved?
- Piramal Healthcare (Canada) Limited holds 8 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Piramal Healthcare (Canada) Limited's drugs manufactured?
- At registered sites in Canada, the United Kingdom, India, the United States. The FDA register lists Aurora; Northumberland; Stirlingshire; Ahmedabad; Navi Mumbai; Pithampur, and 2 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, particle size reduction.
- What drugs does Piramal Healthcare (Canada) Limited make?
- 86 products are listed under Piramal Healthcare (Canada) Limited in the openFDA NDC Directory, most often as powder; injection; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.